Why stopping a prescription is harder than starting one
The medical system is designed to initiate drug treatments but offers little support for discontinuing them, as seen with antidepressants and other long-term medications. Clinical trials rarely study long-term use or withdrawal, and financial incentives favor continued prescribing. This lack of guidance can lead to prescription cascades and serious side effects, especially for older patients.
The article points to a structural gap in medical research, noting that clinical trials typically span only weeks, leaving long-term drug effects and withdrawal processes largely unexamined. This evidence vacuum shapes clinical guidance—or rather, its absence—for physicians managing patients on chronic medications.
The piece cites prescription cascades as a particular concern, where side effects from one drug prompt additional prescriptions rather than reconsideration of the original treatment. Older patients managing multiple health conditions face heightened vulnerability, while financial incentives throughout the healthcare system continue to favor prescribing over deprescribing.
The article suggests that patients on long-term medications may face significant challenges when attempting to discontinue treatment, with limited medical support available. This could affect millions taking antidepressants and other chronic medications, potentially leading to prolonged unnecessary drug exposure, avoidable side effects, and increased healthcare costs. Older adults managing multiple prescriptions may be particularly impacted, as prescription cascades can compound health problems. The lack of deprescribing research and guidance may leave both patients and physicians navigating withdrawal without adequate evidence-based support, though the article's framing suggests this is a systemic issue requiring broader attention.